首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Canadian liver journal

缩写:

ISSN:N/A

e-ISSN:2561-4444

IF/分区:1.2/Q4

文章目录 更多期刊信息

共收录本刊相关文章索引281
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Chinmay Bera,Mina Fakhriyehasl,Nashla Hamdan Perez et al. Chinmay Bera et al.
Background: Significant fibrosis (≥stage 2) in patients with metabolic dysfunction-associated steatotic liver disease (MASLD) is considered a high risk for morbidity and mortality. The magnetic resonance elastography (MR...
Aashish Chalasani,Alice Unah Lee Aashish Chalasani
Background: Non-cirrhotic portal hypertension from a portal vein thrombus can cause variceal bleeding. The use of vasoactive agents such as octreotide is currently limited to acute bleeding episodes. Current strategies to...
Bryce Tkachuk,Matthew Robrigado,Sarah Blayney et al. Bryce Tkachuk et al.
Background: The Cirrhosis Care Alberta (CCAB) Project has created an expert-guided educational video for patients with decompensated cirrhosis. The effect of this video on improving disease-related knowledge in patients w...
Nawaf T Aboalfaraj,Rana K Talab,Alexander R Hemy et al. Nawaf T Aboalfaraj et al.
Background: Hepatic encephalopathy (HE) is a neuropsychiatric syndrome resulting from liver dysfunction, leading to significant cognitive and motor impairments. These impairments can severely affect daily activities, incl...
Shubhreet Gill,Rizwan Shahid,Ranjani Somayaji et al. Shubhreet Gill et al.
Introduction: Despite significant global efforts towards eliminating hepatitis C virus (HCV) infection, multiple challenges remain in achieving this goal. In this study, we assessed the impact of geographical variation on...
George Zacharia,Anu Jacob,Manivarnan Karichery et al. George Zacharia et al.
Treatment of hypercholesterolemia with statins is considered one of the cornerstones in the management of atherosclerotic cardiovascular diseases. Statins exert their hypolipidemic effects by inhibiting HMG-CoA reductase, the key enzyme in ...
Nicole Wiebe,Ashley Stueck,Magnus McLeod Nicole Wiebe
Background: Steatotic liver disease (SLD) may be caused by cardiometabolic risk factors, drugs/toxins, viral hepatitis, genetic diseases, malnutrition, or panhypopituitarism. SLD can advance to steatohepatitis with result...